Adaptive platform trial for stroke

This trial is testing different treatments for stroke patients to find which work best. It's designed to adapt over time so new treatments can be added as research progresses.

This trial tests an investigational sublingual tablet called Y-6 for people having an acute ischemic stroke (a stroke caused by a clot). It may help improve recovery when given within 24 hours of stroke onset, alongside standard endovascular treatment to remove the clot.

This study tests a combination of digital education and peer support to help young and middle-aged stroke survivors recover. It aims to see if sharing information and connecting with others can improve your recovery journey.

This trial tests a traditional Chinese medicine (Angong Niuhuang Wan) given within 6 hours of a bleeding stroke. It aims to see if this treatment helps people recover better and reduces disability after a stroke.

This trial studies different doses of a targeted brain stimulation technique to treat aphasia (language problems) after a first stroke. If you qualify, the goal is to see whether the treatment can improve your ability to understand and speak.

This study is collecting information on stroke patients who received the clot-dissolving drug tenecteplase. It aims to see how well the drug works and how safe it is in everyday hospital care in China.